User login
The U.S. House of Representatives passed the 21st Century Cures Act (H.R. 6) Friday, July 10, by an overwhelming margin, with 344 members voting in favor of the legislation. This bill is intended to help bring the U.S. health care system into the 21st century by investing in scientific and medical innovation, incorporating the patient perspective, and modernizing clinical trials to deliver better, faster cures to more patients in need. Specifically, the act calls for increasing funding for medical research at the National Institutes of Health and the Food and Drug Administration, as well as rewriting procedures for approval of drugs and medical devices. Learn more about the legislation at https://www.congress.gov/bill/114th-congress/house-bill/6.
H.R. 6 would cost approximately $98 billion to implement over 10 years, according to an analysis from the Congressional Budget Office (CBO). The CBO also estimates that the legislation would decrease federal deficits by $518 million over 10 years.
The Senate will likely consider its companion legislation in early 2016. The White House has said it looks forward to working with Congress as the legislation moves forward.
The U.S. House of Representatives passed the 21st Century Cures Act (H.R. 6) Friday, July 10, by an overwhelming margin, with 344 members voting in favor of the legislation. This bill is intended to help bring the U.S. health care system into the 21st century by investing in scientific and medical innovation, incorporating the patient perspective, and modernizing clinical trials to deliver better, faster cures to more patients in need. Specifically, the act calls for increasing funding for medical research at the National Institutes of Health and the Food and Drug Administration, as well as rewriting procedures for approval of drugs and medical devices. Learn more about the legislation at https://www.congress.gov/bill/114th-congress/house-bill/6.
H.R. 6 would cost approximately $98 billion to implement over 10 years, according to an analysis from the Congressional Budget Office (CBO). The CBO also estimates that the legislation would decrease federal deficits by $518 million over 10 years.
The Senate will likely consider its companion legislation in early 2016. The White House has said it looks forward to working with Congress as the legislation moves forward.
The U.S. House of Representatives passed the 21st Century Cures Act (H.R. 6) Friday, July 10, by an overwhelming margin, with 344 members voting in favor of the legislation. This bill is intended to help bring the U.S. health care system into the 21st century by investing in scientific and medical innovation, incorporating the patient perspective, and modernizing clinical trials to deliver better, faster cures to more patients in need. Specifically, the act calls for increasing funding for medical research at the National Institutes of Health and the Food and Drug Administration, as well as rewriting procedures for approval of drugs and medical devices. Learn more about the legislation at https://www.congress.gov/bill/114th-congress/house-bill/6.
H.R. 6 would cost approximately $98 billion to implement over 10 years, according to an analysis from the Congressional Budget Office (CBO). The CBO also estimates that the legislation would decrease federal deficits by $518 million over 10 years.
The Senate will likely consider its companion legislation in early 2016. The White House has said it looks forward to working with Congress as the legislation moves forward.